Ginkgo Bioworks will provide in-kind robotic laboratory access and protein testing services to researchers involved in the National Science Foundation's $1.5 billion X-Labs initiative. The announcement strengthens its position in publicly supported autonomous research infrastructure, but the programme's headline funding is not a contract award to Ginkgo.
Guardant360 CDx gains European CE marking for ETCAMAH patient selection. See how ESR1 blood testing changes advanced breast cancer treatment.
BetterUp Canada's Ontario study tests six months of virtual coaching for first responders, examining stress, resilience and workplace mental health.
bioAffinity Technologies closes $4 million financing as CyPath Lung sales grow. Examine dilution, cash runway and commercial expansion.
Corcym's Perceval Plus reports 99.7% freedom from valve deterioration in extended follow-up. Examine the MANTRA data and durability questions.
Carrot's GreenMan acquisition adds cataract lens simulation, backed by a 609-patient study, as VR eye-care technology expands beyond diagnostics.
Urolution Medical's OpenFlo catheter gains FDA clearance for 30-day drainage. Clinical studies and manufacturing will determine its next steps.
Stuart Therapeutics files an FDA amendment for ST-100 corneal wound trials, with collagen repair evidence and 2027 milestones in focus.
Glaukos iDose TR shows an additional 3.6 mmHg pressure reduction with cataract surgery. Examine the Phase 4 data and adoption implications.
Ascensia backs Sava's $36M glucose microsensor push, but clinical validation and CE marking remain critical before its planned European launch.